Novo Nordisk Gears Up for ORION Showdown as Obesity Congress Highlights Pill and Pipeline Gains
At the European Obesity Congress, Novo Nordisk presents 52 studies, with oral Wegovy facing Eli Lilly’s Foundayo in…
Browsing Tag